These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2311648)

  • 1. Macrophage-secreted prostaglandin E2 potentiates immune complex-induced B cell unresponsiveness.
    Stein SH; Phipps RP
    Eur J Immunol; 1990 Feb; 20(2):403-7. PubMed ID: 2311648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
    Schad VC; Phipps RP
    J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of intracellular cAMP sensitize resting B lymphocytes to immune complex-induced unresponsiveness.
    Stein SH; Phipps RP
    Eur J Immunol; 1991 Feb; 21(2):313-8. PubMed ID: 1847875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific IGG2A production in response to prostaglandin E2, immune complexes, and IFN-gamma.
    Stein SH; Phipps RP
    J Immunol; 1991 Oct; 147(8):2500-6. PubMed ID: 1655892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for macrophages: the ability of macrophages to tolerize B cells.
    Phipps RP; Scott DW
    J Immunol; 1983 Nov; 131(5):2122-7. PubMed ID: 6195250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-dependent induction of B cell unresponsiveness. Role of surface Ig and Fc receptors.
    Schad V; Phipps RP
    J Immunol; 1989 Oct; 143(7):2127-32. PubMed ID: 2506277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic presentation of an immunoglobulin "tolerogen" requires interleukin 2.
    Sadegh-Nasseri S; Phipps RP
    Eur J Immunol; 1988 Mar; 18(3):417-23. PubMed ID: 2451614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B cell tolerance by macrophage-derived mediators: antagonistic effects of prostaglandin E2 and interleukin 1.
    Goldings EA
    J Immunol; 1986 Feb; 136(3):817-22. PubMed ID: 2416834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of tolerogenic immunoglobulin in vivo by macrophages and by a lymphoid dendritic cell-like tumor line.
    Phipps RP; Illig K; Schad V; Bhimani K
    J Leukoc Biol; 1988 Mar; 43(3):271-8. PubMed ID: 3257790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell tolerance. I. Analysis of hapten-specific unresponsiveness induced in vitro in adult and neonatal murine spleen cell populations.
    Cambier JC; Uhr JW; Kettman JR; Vitetta ES
    J Immunol; 1977 Dec; 119(6):2054-9. PubMed ID: 72117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hapten-induced B cell paralysis. II. Evidence for trivial mechanisms of tolerance.
    Gronowicz E; Coutinho A
    Eur J Immunol; 1976 Jun; 5(6):413-20. PubMed ID: 1086240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells.
    Ferguson AR; Youd ME; Corley RB
    Int Immunol; 2004 Oct; 16(10):1411-22. PubMed ID: 15326094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.
    El Shikh ME; El Sayed RM; Szakal AK; Tew JG
    J Immunol; 2009 Mar; 182(6):3482-91. PubMed ID: 19265126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
    Cogswell JP; Phipps RP; Scott DW
    J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a tolerogenic to an immunogenic signal by P388AD.2 cells, a lymphoid dendritic cell-like tumor line.
    Phipps RP; Pillai PS; Scott DW
    J Immunol; 1984 May; 132(5):2273-8. PubMed ID: 6201539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release. Evidence for an Fc receptor.
    Sedor JR; Carey SW; Emancipator SN
    J Immunol; 1987 Jun; 138(11):3751-7. PubMed ID: 3035013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of second signals on the induction of B cell tolerance: failure of helper T cells to block tolerance induction.
    Cambier JC; Corley RB
    Eur J Immunol; 1981 Jul; 11(7):550-6. PubMed ID: 6169534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.